Improving Care in Eosinophil-Associated Diseases: A Charter.

Jackson, David J; Akuthota, Praveen; Andradas, Rebeca; Bredenoord, Albert J; Cordell, Amanda; Gray, Sarah; Kullman, Joyce; Mathur, Sameer K; Pavord, Ian; Roufosse, Florence; Rubio, Christian; Rusek, Irena Clisson; Simon, Dagmar; Strobel, Mary Jo; Winders, Tonya (2022). Improving Care in Eosinophil-Associated Diseases: A Charter. Advances in therapy, 39(6), pp. 2323-2341. Springer 10.1007/s12325-022-02110-8

[img]
Preview
Text
Jackson2022_Article_ImprovingCareInEosinophil-Asso.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (465kB) | Preview

Eosinophil-associated diseases (EADs) are a range of heterogeneous conditions in which eosinophils are believed to play a critical pathological role. EADs include common illnesses such as eosinophilic asthma and chronic rhinosinusitis and rare conditions such as hypereosinophilic syndromes (HES) and eosinophilic gastrointestinal disorders (EGIDs). EADs are associated with substantial burdens for the patient, including chronic, debilitating symptoms, increased financial burden, decreased health-related quality of life, and the need for repeated visits to multiple different healthcare professionals (HCPs), emergency departments, and/or hospitals. Poor EAD recognition by HCPs often contributes to delayed diagnoses, which further delays patient access to appropriate care and effective treatments, contributing to poor health outcomes. The objective of this charter is to outline key patient rights and expectations with respect to the management of their condition(s) and to set forth an ambitious action plan to improve health outcomes for patients with EADs: (1) people with EADs, their caretakers, HCPs, and the public must have greater awareness and education about EADs; (2) people with EADs must receive a timely, accurate diagnosis; (3) all people with EADs must have access to an appropriate multidisciplinary team, when necessary; and (4) people with EADs must have access to safe and effective treatment options without unnecessary regulatory delays. The principles described in this charter demonstrate the core elements of quality care that people with EADs must receive, and they represent clear steps by which to reduce patient and caregiver burden and improve patient outcomes. We urge HCPs, healthcare systems, and policymakers worldwide to swiftly adopt these principles to ensure patients with EADs have an accurate diagnosis in a timely manner and access to high-level care and treatment in an appropriate setting.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Simon, Dagmar

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0741-238X

Publisher:

Springer

Language:

English

Submitter:

Pubmed Import

Date Deposited:

02 May 2022 07:19

Last Modified:

22 May 2022 00:17

Publisher DOI:

10.1007/s12325-022-02110-8

PubMed ID:

35489014

Uncontrolled Keywords:

Eosinophil-associated diseases Eosinophilic immune dysfunction (EID) Healthcare professional (HCP) education Multidisciplinary teams (MDTs) Patient education Patient rights Timely diagnosis

BORIS DOI:

10.48350/169646

URI:

https://boris.unibe.ch/id/eprint/169646

Actions (login required)

Edit item Edit item
Provide Feedback